Today: 13 June 2026
IBM stock slides into 2026 — filings and Jan. 28 earnings set the next test
4 January 2026
2 mins read

IBM stock slides into 2026 — filings and Jan. 28 earnings set the next test

NEW YORK, Jan 4, 2026, 14:40 ET — Market closed

  • IBM shares fell 1.6% on Friday, lagging a modest rise in U.S. blue-chip stocks.
  • A director disclosure showed a routine deferral of board fees into stock-linked units.
  • The next catalysts include the Jan. 9 U.S. jobs report and IBM’s scheduled Jan. 28 earnings date.

International Business Machines (IBM.N) shares fell 1.6% to $291.50 on Friday, even as the Dow Jones Industrial Average ended higher. The stock traded between $289.00 and $297.57 and remains below its 52-week high of $324.90, according to market data.

The early-year stumble matters because IBM sits at the intersection of enterprise software, infrastructure and consulting, where sentiment can turn quickly when budgets tighten. With U.S. markets closed for the weekend, investors are mapping out the next set of macro and company checkpoints that typically reset positioning.

IBM’s investor calendar lists Jan. 28 as a preliminary date for its fourth-quarter earnings announcement. The update is expected to refocus attention on software growth, consulting demand and the pace at which IBM is turning corporate AI spending into revenue and cash.

From a technical standpoint, traders have marked Friday’s low near $289 as near-term support, with the high-$290s acting as a first resistance zone. A decisive move outside that band has tended to draw fast money back into the name.

A Form 4 filing dated Dec. 31 showed board member Alex Gorsky deferred fees into 363 “Promised Fee Shares,” a stock-linked unit under IBM’s director deferred-compensation plan. The filing said the units are paid out after retirement in IBM common stock or cash. SEC

Friday’s session also underscored how stock-specific moves can get swamped by the broader tape at the start of a new year. Chip stocks lifted the market while some heavyweight tech names fell, Reuters reported, and “buy the dip, sell the rip” remains the prevailing mentality, Joe Mazzola, head of trading and derivatives strategy at Charles Schwab, told Reuters. Reuters

The next earnings report will land after IBM’s October quarter, when the company beat estimates on demand for AI-powered mainframe systems, even as growth slowed in its Red Hat hybrid cloud unit, Reuters reported. The balance between hardware cycles, higher-margin software and services remains a central driver of the stock’s multiple.

IBM is also working through deal-related questions after it agreed in December to buy data-streaming company Confluent for $31 a share in cash, valuing the transaction at $11 billion. IBM said the acquisition is expected to close by mid-2026, subject to shareholder and regulatory approvals, as it pushes to strengthen its data platform for generative and “agentic” AI. IBM Newsroom

But IBM heads into the next stretch with little room for a misstep: any renewed slowdown in Red Hat’s growth or a pullback in IT services budgets would test the durability of the trade. Investors are also likely to probe for specifics on integration timing and costs tied to the Confluent transaction.

The market’s next macro catalyst is the U.S. employment report for December, due at 8:30 a.m. ET on Jan. 9. After that, attention shifts to IBM’s Jan. 28 earnings date for the clearest read yet on 2026 demand trends and any updated outlook.

Stock Market Today

  • Axon Enterprise Stock Review: Valuation and Recent Price Volatility
    June 13, 2026, 1:39 AM EDT. Axon Enterprise (AXON) closed at $441.73 amid share price volatility, declining 1.0% in 1 day and 9.13% over 7 days, despite a 30-day gain of 17.23%. The 1-year shareholder return stands at a 43.41% decline. Analysts suggest a fair value estimate of $606.83, indicating the stock may be undervalued by 27.2%. Axon's shift from hardware to a software and data platform for public safety underpins growth potential. However, the stock trades at a rich price-to-sales (P/S) ratio of 11.9x, compared to the aerospace/defense industry average of 5.6x, reflecting valuation risks if market sentiment shifts or budget constraints arise. Investors should weigh Axon's long-term platform economics against potential headwinds in public sector spending and competitive pressures.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Previous Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Chevron caught in Venezuela oil clamp as PDVSA cuts output under U.S. embargo
Next Story

Chevron caught in Venezuela oil clamp as PDVSA cuts output under U.S. embargo

Go toTop